Gabriella Giagnoni

The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain

Barbara Costa, Anna Elisa Trovato, Francesca Comelli et al. · European Journal of Pharmacology · 2006 · 379 citations

Effective Therapeutic Agent, Cannabis Use, Pain Therapy +12

The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPARγ receptors and neurotrophic factors

Barbara Costa, Francesca Comelli, Isabella Bettoni et al. · Pain · 2008 · 283 citations

Pain Therapy, Pain Disorders, Pain Medicine +22

Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation

Barbara Costa, Gabriella Giagnoni, Chiara Franke et al. · British Journal of Pharmacology · 2004 · 276 citations · Full text

Pain Medicine, Immunology, Molecular Pain +17

Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw

Barbara Costa, Mariapia Colleoni, Silvia Conti et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2004 · 239 citations

Inflammation, Cannabis Use, Anti-inflammatory +7

Glial TLR4 receptor as new target to treat neuropathic pain: Efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice

Isabella Bettoni, Francesca Comelli, Clara Rossini et al. · Glia · 2008 · 199 citations

Peripheral Nerve Injury, Pain Medicine, Immunology +20